Myeloperoxidase as a biomarker of skin irritation and inflammation

M A Trush1, P A Egner, T W Kensler

  • 1Department of Environmental Health Sciences, Johns Hopkins School of Hygiene and Public Health, Baltimore, MD 21205.

Insights

Myeloperoxidase (MPO) accumulation in skin effectively indicates inflammation caused by chemical exposure. This enzyme serves as a reliable biomarker for assessing dermal irritancy and potential toxicity.

Area of Science:

  • Toxicology
  • Dermatology
  • Biochemistry

Background:

  • Chemical exposure can trigger skin inflammation, involving polymorphonuclear leucocytes (PMNs).
  • Assessing dermal inflammatory responses is crucial for understanding chemical toxicity.

Purpose of the Study:

  • To evaluate myeloperoxidase (MPO) accumulation as a biomarker for skin inflammation.
  • To determine the utility of MPO as a toxicological tool for assessing dermal irritancy.

Main Methods:

  • Measuring myeloperoxidase (MPO) levels in skin following chemical exposure.
  • Comparing MPO accumulation with morphometric indicators of polymorphonuclear leucocytes (PMNs).

Main Results:

  • A strong correlation was observed between MPO accumulation and PMN influx.
  • MPO levels accurately reflected the inflammatory response to various skin irritants and tumor promoters.

Conclusions:

  • Myeloperoxidase (MPO) accumulation is a sensitive indicator of chemical-induced dermal inflammation.
  • MPO serves as a valuable toxicological tool for assessing chemical irritancy and potential skin damage.

Related Concept Videos